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Background: Primary mesenchymal chondrosarcoma of the kidney is an extremely rare malignant tumor. To our
best knowledge, only 9 such cases have been reported so far.
Case presentation: In the current paper, we present the case of a 67 year-old patient with recurrent left lumbar
pain, increased fatigability and intermittent macroscopic hematuria. He underwent a surgical resection of the left
kidney and left hemicolon.
The pathological diagnosis was primary extraskeletal renal mesenchymal chondrosarcoma. Overall survival was
9 months, with pulmonary metastasis and local recurrence at 6 months. The management of the patient is
described, from the initial differential diagnosis, after the first clinical examination to the surgical resection, with a
special emphasis on the surgical procedures that were carried out.
Conclusion: Extraskeletal chondrosarcoma of primary origin in the kidney are extremely rare tumors with a highly
malignant potential and very poor prognosis. Because the role of chemotherapy or radiation therapy has not been
evaluated properly yet, we underline the importance of surgery in the management of such cases as the main and
best approach to achieve clinical remission and long-term survival, provided the patient is referred to a surgical
consult in time.
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Mesenchymal chondrosarcomas (MC) were initially de-
scribed by Lichtenstein and Bernstein more than 50 years
ago as rare tumors that affect the bone tissue [1], other
case reports followed from the surgical department of the
Mayo Clinic in Rochester, USA [2]. Pathologists separate
mesenchymal chondrosarcomas from other classical or
de-differentiated chondrosarcomas due to a specific histo-
logical pattern formed of highly undifferentiated small
round cells, admixed with islands of well-differentiated
hyaline cartilage [3,4]. Epidemiology data state that MCs
represent about 2% of all chondrosarcoma cases and
usually arise in the osseous tissue of the adult skeleton
[5]. Nevertheless, several reports show that MCs may be* Correspondence: ciprian.tomuleasa@umfcluj.ro
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unless otherwise stated.diagnosed in other soft tissues that are not directly asso-
ciated to the bone, such as the axillary region, the heart,
the thyroid gland, the pancreas, orbital region or even
the kidney [6-11]. Such diagnoses are challenging due to
their rarity and paucity of reports.
In the current paper, we report description of the surgi-
cal management of a renal MC, an extremely rare condi-
tion to our knowledge, with only nine other cases having




In the current paper, we present the case of a 67 year-old
patient who was hospitalized with recurrent left lumbar
pain, increased fatigability and intermittent macroscopic
hematuria. On clinical examination, a large tumor was no-
ticed on the left side. The routine laboratory tests showed
that out patient had anemia and hypercalcemia. Ultrason-
ography revealed a giant, heterogeneous tumor mass ofal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 H&E staining. Biphasic tumor (A). Hemangioperycitomatous
pattern (B).
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well as multiple hyperechogenous regions. The abdominal
computer tomography (CT) (Figure 1) confirmed our pre-
vious clinical diagnosis, showing a huge left renal tumor
of 30 cm in its largest diameter. The excretory function of
the left kidney was inexistent, with no evidence of retro-
peritoneal lymphadenopathy, as well as no evidence of a
thrombus of the renal vein or secondary metastatic dis-
semination. Routine Rx of the chest did not reveal the
presence of lung metastasis.
As safety and accuracy of percutaneous biopsy was re-
cently reported by Volpe et al [18], we have performed a
fine needle aspiration biopsy of this radiological undeter-
mined renal mass, in order to establish the diagnosis and
to assess the potential role of the neoadjuvant chemo-
therapy. The pathological examination showed well differ-
entiated, benign appearing cartilaginous tissue, raising the
suspicion of a chondrosarcoma, osteosarcoma or another
cartilage producing tumor (Figure 2).
Within the tumour board of the Cancer Center, the
oncologist sustained the idea of neoadjuvant chemother-
apy with cisplatin and doxorubicin. Still, the performance
status of the patient did not allowed optimal clinical man-
agement, as tumour progression was assessed, and surgery
was imperative. Soon after the percutaneous biopsy was
done, the general condition of the patient began to worsen,
as weight loss was noticed along with a diagnosis of
sub-occlusive syndrome. The surgical indication was of
a left radical nephrectomy and left hemicolectomy, as
further described.
Surgical management
The first step was to place the patient in a supine pos-
ition in an extended bed at about 30 degrees below theFigure 1 Abdominal CT sowing the huge renal tumor.lumbar space. The operation begun with a bilateral sub-
costal incision (Chevron incision) completed with a left
para-rectal extension and an intercostal branch. The in-
spection of the abdominal cavity revealed a giant left renal
mass of 35 cm in the largest diameter, with a cystic ap-
pearance and liquid content, which was highly adherent to
the mesocolon. Palpation and detailed inspection of the
other intraperitoneal organs did not reveal any noticeable,
macroscopic metastases, except the mesocolon, surround-
ing lymph nodes were not enlarged.
Because of its volume, and severely modified loco-
regional anatomy, manipulation was difficult and the
excision of the tumour in a “non-touch technique”, with
the primary ligation of the vascular supply, was virtually
impossible. Excision was only possible after the evacu-
ation of the intratumoral content of about 2500 cc of
serosanguinous, viscous and gelatinous liquid, using all
the available methods to minimize intraperitoneal tumoral
spillage (high-power vacuum, hypertonic solutions, pro-
tection of the intra-abdominal organs with sterile, water-
tight materials).
Figure 4 CT scan 6 months after surgery. Massive local relapse.
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the tumor, the dissection of the mesocolon from the
Gerota’s fascia, as initially planned, was virtually impos-
sible. The intraoperative decision was to perform a left
hemicolectomy with a termino-terminal anastomosis of
the colon. After this step was finished successfully, hav-
ing the resected colon reflected laterally, the surgeons
were able to correctly identify the elements of the renal
hilum. First, the renal vein was mobilized completely by
ligating and dividing all its tributaries. The next proced-
ure was to identify the renal artery, followed by its
ligation and dividing. Similar management was per-
formed for the renal vein and for the ureter. The kidney
was mobilized outside the Gerota’s fascia, using both
sharp and blunt dissections, together with the ipsilateral
adrenal gland and approximately 20 cm of the mesoco-
lon (Figure 3).
Results
The total time of the surgery was 210 minutes, and the pa-
tient had a blood loss of approximately 2000 ml. In post-
operative patient received broad spectrum antibiotics and
3 units of blood. After the surgical intervention was fin-
ished successfully, the recovery of the patient was slow,
but favorable. He was discharged 10 days after surgery. As
the patient had a high risk for recurrence due to the posi-
tive surgical margins and tumour aggressiveness, the clin-
ical management consisted of an intensified follow-up
algorithm, in accordance with the guidelines and radiation
regulations [19,20]. The first CT performed at two months
after the surgery, showed no recurrence or metastasis. CT
scan performed at six months after the surgery showed
pulmonary metastasis and a massive local relapse (extend-
ing from the psoas muscle, encompassing and displacing
aorta (Figure 4).
After the consult of the medical oncologist, it was con-
firmed that the patient had a stage IV tumor and noFigure 3 The giant tumoral kidney of 35 cm.salvage chemotherapy was appropriate, taking into con-
siderations his comorbidities and poor performance status.
Supportive care and pain management was recommended
and pursued until the patient died three more months later,
at approximately 9 months after the surgery.
Pathology diagnosis
The whole specimen was fixed in 10% formalin. After
fixation, multiple specimens where paraffin embedded
sectioned 4 micrometers thick and coloured with
haematoxylin-eosin (H&E). Microscopical examination
revealed a pushing biphasic tumor, composed of large
sheets of undifferentiated round or slightly spindle-shaped
cells arranged in a hemangioperycitomatous pattern, and
islands of well differentiated cartilage, with no transition
zone between them. The histological picture included foci
of osteoid, ossification and calcification, haemorrhage and
necrosis. The remaining renal parenchyma showed areas
of coagulative necrosis; the tumour did not invade the
renal pelvis, but it was extended beyond perinephric tis-
sues into Gerota’s fascia, and paranehric fat, with no evi-
dence of infiltration into renal vein (pT4NxM0V0R1).
As tumour spread also involved the paranephric fat, sur-
geons were not able to obtain completely clean surgical
margins (R0). The colon and the adrenal were free of
tumour. The concluding diagnosis was extrascheletal
MC of the kidney.
Discussions
Extraskeletal chondrosarcomas are rare neoplasms, far
less common in comparison with the osseous ones [21]
and pathologists separate these cases into two different
subtypes: myxoid and mesenchymal. In contrast with the
myxoid subtypes, the mesenchymal chondrosarcomas
are diagnosed even in fewer cases and are very aggressive
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and 23.7% [6]. As previously stated, literature search lim-
ited to the English, French and German language
unearthed very few cases of MC, especially for the ones lo-
cated in the kidney. These cases are different from a typ-
ical chondrosarcoma in several aspects. First, they are of
extraskeletal origin, so a thorough skeletal search is essen-
tial for a correct differential diagnosis between a metastatic
MC and one with a primary extraskeletal localization. MC
show a predilection for middle aged males, whereas extra-
skeletal MC are diagnosed more frequently in females and
have a higher incidence in the nervous system for the ones
in their 20s and other soft tissues above the age of 40 [23].
Because of their rarity and lack of appropriate studies
and clinical trials to assess the best treatment of choice,
there are no international accepted guidelines for the
management of primary renal MC. Huvos et al. further
divided the patients into two groups based on the patho-
logical diagnosis: undifferentiated small cell types and
hemangiopericytomatoid type [24], but his protocols are
valid for primary skeletal tumors and no guidelines were
mentioned for the cases of extraskeletal origin. Later,
Knott et al. and Rushing et al. suggest some guidelines
regarding the wide margins for the surgical resection for
these very rare cases [25], but he did not mention any
standard-of-care for primary renal MC.
Systemic chemotherapy or radiation therapies have an
unknown role for these cases due to absence of objective
evidence [26]. Still, since the excision was not performed
following the steps of the “non-touch technique” [27],
and because tumoral spillage represented a real possibil-
ity, the role of intraperitoneal chemotherapy [28] should
have been assessed, as this method showed encouraging
results in other types of cancer. Data are scarce for
extraskeletal MC and even less data is available to evalu-
ate the best treatment option for the ones that have a
renal primary localization. Our study is very rare and the
interdisciplinary consensus panel of the Clinical Municipal
Hospital and Ion Chiricuta Comprehensive Cancer Center
suggested that the best management is neoadjuvant chemo-
therapy followed by a wide surgical resection, reported in
the current paper. This makes our case one of the very
few reports that try to establish a standard-of-care for fu-
ture patients diagnosed with similar tumors.
Mesenchymal chondrosarcomas are highly malignant
and have a propensity to metastasize especially to the
lungs [5], as was the case in our patient. This makes the
accurate diagnosis the first important step, based on the
characteristic clinical, radiological and histopathological
features. Furthermore, based on our experience, we can
emphasize the importance of surgery in the management
of such cases as the main and best approach to achieve
clinical remission and long-term survival, provided the
patient is referred to a surgical consult in time.Conclusion
Extraskeletal chondrosarcoma of primary origin in the
kidney are extremely rare tumors with a highly malignant
potential and very poor prognosis. Because the role of
chemotherapy or radiation therapy has not been evaluated
properly yet, the main treatment-of-choice is a wide surgi-
cal resection with clean margins, after an early and correct
diagnosis has been made.
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